Vir Biotechnology (VIR) currently reports a current cash of $280M as of June 2026. That compares with $300M in the prior-year period — down 6.9% year over year. Use the charts on this page to explore Vir Biotechnology's current cash history and peer comparisons.

Vir Biotechnology's current cash decreased from $300M to $280M — a 6.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vir Biotechnology reported $280M in current cash as of June 2026. That compares with $300M in the prior-year period — down 6.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $280M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vir Biotechnology, and consider following VIR for alerts when major investors trade the stock.

Vir Biotechnology is classified in the Healthcare sector. On current cash, it currently shows $280M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VIR with unrelated industries.